Quick Order

Text Size:AAA

SFTPD / SP-D / SFTP4 Antibody, Rabbit PAb, Antigen Affinity Purified

DatasheetReviewsRelated ProductsProtocols
Cynomolgus SFTPD Antibody Product Information
Immunogen:Recombinant Cynomolgus SFTPD / SP-D / SFTP4 protein (Catalog#90003-C08H)
Clone ID:
Ig Type:Rabbit IgG
Concentration:
Formulation:0.2 μm filtered solution in PBS with 5% trehalose
Preparation:Produced in rabbits immunized with purified, recombinant Cynomolgus SFTPD / SP-D / SFTP4 (rC SFTPD / SP-D / SFTP4; Catalog#90003-C08H; NP_001035283.1; Met 1-Phe 375). SFTPD / SP-D / SFTP4 specific IgG was purified by Cynomolgus SFTPD / SP-D / SFTP4 affinity chromatography.
Cynomolgus SFTPD Antibody Usage Guide
Specificity:Cynomolgus SFTPD / SP-D / SFTP4
Application:ELISA

ELISA: 0.1-0.2 μg/mL

This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Cynomolgus SFTPD. The detection limit for Cynomolgus SFTPD is approximately 0.00245 ng/well.

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Other SFTPD Antibody Products
Reactivity: Human  
Application: ELISA  
    11041-RP01-100
    11041-RP01-200
    11041-RP01-400
    100 µg 
    200 µg 
     
    Add to Cart
    Reactivity: Mouse  
    Application: ELISA  
      50205-RP01-400
      50205-RP01-100
      50205-RP01-200
       
      100 µg 
      200 µg 
      Add to Cart
      Reactivity: Mouse  
      Application: ELISA  IHC-P  
      • Slide 1
      50205-RP02-200
      50205-RP02-50
      50205-RP02-100
      200 µg 
      50 µg 
      100 µg 
      Add to Cart
      Reactivity: Mouse  
      Application: ELISA  
        50205-R019-50
        50205-R019-100
        50 µg 
        100 µg 
        Add to Cart
        Reactivity: Mouse  
        Application: IHC-P  
        • Slide 1
        50205-R119-100
        50205-R119-50
        100 µg 
        50 µg 
        Add to Cart
        Reactivity: Cynomolgus  
        Application: ELISA  
          90003-R111-50
          90003-R111-100
          50 µg 
          100 µg 
          Add to Cart
          Reactivity: Cynomolgus  
          Application: ELISA  
            90003-RP01-100
            90003-RP01-200
            90003-RP01-400
            100 µg 
            200 µg 
             
            Add to Cart
            Reactivity: Rhesus  
            Application: IHC-P  
            • Slide 1
            90003-R001-100
            90003-R001-50
            100 µg 
            50 µg 
            Add to Cart
            SFTPD/SP-D Background

            Surfactant pulmonary-associated protein D, also known as SFTPD and SP-D, is a member of the collectin family of C-type lectins that is synthesized in many tissues including respiratory epithelial cells in the lung, and contains one C-type lectin domain and one collagen-like domain. The polymorphic variation in the N-terminal domain of the SP-D molecule influences oligomerization, function, and the concentration of the molecule in serum. SFTPD is produced primarily by alveolar type II cells and nonciliated bronchiolar cells in the lung and is constitutively secreted into the alveoli where it influences surfactant homeostasis, effector cell functions, and host defense. It is upregulated in a variety of inflammatory and infectious conditions including Pneumocystis pneumonia and asthma. SFTPD is humoral molecules of the innate immune system, and is considered a functional candidate in chronic periodontitis. Besides it is involved in the development of acute and chronic inflammation of the lung. Several human lung diseases are characterized by decreased levels of bronchoalveolar SFTPD. Thus, recombinant SFTPD has been proposed as a therapeutical option for cystic fibrosis, neonatal lung disease and smoking-induced emphysema. Furthermore, SFTPD serum levels can be used as disease activity markers for interstitial lung diseases.

            Cynomolgus SFTPD/SP-D References
          • Leth-Larsen R, et al. (2005) A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol. 174(3): 1532-8.
          • Moran AP, et al. (2005) Role of surfactant protein D (SP-D) in innate immunity in the gastric mucosa: evidence of interaction with Helicobacter pylori lipopolysaccharide. J Endotoxin Res. 11(6): 357-62.
          • Hartl D, et al. (2006) Surfactant protein D in human lung diseases. Eur J Clin Invest. 36(6): 423-35.
          • Krueger M, et al. (2006) Amino acid variants in Surfactant protein D are not associated with bronchial asthma. Pediatr Allergy Immunol. 17(1): 77-81.
          • Glas J, et al. (2008) Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker. Tissue Antigens. 72(1): 21-8.
          • Product nameProduct name
            All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
            Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"